Back
Cadrenal Therapeutics, Inc. Stock Predictions
BlackRock's $91B Secret
Learn how to access Native Markets before Coinbase. Watch the free training.
Sell
20
CVKD
Cadrenal Therapeutics, Inc.
Last Price:
$7.48
Seasonality Move:
2.8%
7 Day Trial
ALL ACCESS PASS
$
7
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.Cadrenal Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Cadrenal Therapeutics, Inc. has on average historically fallen by 11.4% based on the past 2 years of stock performance.
-
Cadrenal Therapeutics, Inc. has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Cadrenal Therapeutics, Inc. Stock Undervalued?The current Cadrenal Therapeutics, Inc. [CVKD] share price is $6.78. The Score for CVKD is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
CVKD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Cadrenal Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cadrenal Therapeutics, Inc. has on average historically fallen by 11.4% based on the past 2 years of stock performance.
Cadrenal Therapeutics, Inc. Stock Rating
Sell
20
Cadrenal Therapeutics, Inc. (CVKD)
is a Sell
Is Cadrenal Therapeutics, Inc. overpriced?
-
Cadrenal Therapeutics, Inc. has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Cadrenal Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cadrenal.com
52-Week Data
52-Week High:
22.90
52-Week Low:
6.42
Prediction Charts
Market Cap:
15.2M
Price in USD:
6.78
Volume:
19.6K
Beta:
1.16
Technical Analysis
SMA50:
10.71
SMA100:
11.97
SMA200:
13.20
52-Wk Change:
-52.71%
Stock Predictions
-
Is Cadrenal Therapeutics, Inc. stock public?Yes, Cadrenal Therapeutics, Inc. is a publicly traded company.
-
What is the Cadrenal Therapeutics, Inc. stock quote today?The Cadrenal Therapeutics, Inc. stock price is 6.78 USD today.
-
How to buy Cadrenal Therapeutics, Inc. stock online?You can buy Cadrenal Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-10 | 10.00 | 11.11 | 11.30 | 9.99 |
| Dec-11 | 11.96 | 11.00 | 12.00 | 10.60 |
| Dec-12 | 11.34 | 11.00 | 11.44 | 10.83 |
| Dec-15 | 11.82 | 12.29 | 12.50 | 10.92 |
| Dec-16 | 9.47 | 8.25 | 9.59 | 7.43 |
| Dec-17 | 8.40 | 7.94 | 8.91 | 7.83 |
| Dec-18 | 8.07 | 7.37 | 8.07 | 7.17 |
| Dec-19 | 7.31 | 7.11 | 7.35 | 6.76 |
| Dec-22 | 7.11 | 7.54 | 7.74 | 7.08 |
| Dec-24 | 6.97 | 7.37 | 7.37 | 6.97 |
| Dec-26 | 7.37 | 7.41 | 7.62 | 7.02 |
| Dec-29 | 7.37 | 6.91 | 7.37 | 6.85 |
| Dec-30 | 6.81 | 6.62 | 6.88 | 6.42 |
| Dec-31 | 6.62 | 6.78 | 6.97 | 6.61 |
Cadrenal Therapeutics, Inc. Earnings
Cadrenal Therapeutics, Inc. Earnings Report: Per Share Cadrenal Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cadrenal Therapeutics, Inc. Forecast Revenue Growth
Cadrenal Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cadrenal Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.39 per share, and a decrease next year of $0.89 per share.
* Cadrenal Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.